BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang N, Garcia J, Freeman R, Gibbons CH. Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results. J Histochem Cytochem 2020;68:669-78. [PMID: 32921251 DOI: 10.1369/0022155420960250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Miglis MG, Seliger J, Shaik R, Gibbons CH. A case series of cutaneous phosphorylated α-synuclein in Long-COVID POTS. Clin Auton Res 2022. [PMID: 35570247 DOI: 10.1007/s10286-022-00867-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gibbons CH, Freeman R, Bellaire B, Adler CH, Moore D, Levine T. The Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies. Biomark Med 2022. [PMID: 35272481 DOI: 10.2217/bmm-2021-0646] [Reference Citation Analysis]
3 Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-radford NR, Moussa C, Poston KL, Rosenthal LS, Sabbagh MN, Walsh RR, Weber MT, Armstrong MJ, Bang JA, Bozoki AC, Domoto-reilly K, Duda JE, Fleisher JE, Galasko DR, Galvin JE, Goldman JG, Holden SK, Honig LS, Huddleston DE, Leverenz JB, Litvan I, Manning CA, Marder KS, Pantelyat AY, Pelak VS, Scharre DW, Sha SJ, Shill HA, Mari Z, Quinn JF, Irwin DJ. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Front Neurol 2022;12:805135. [DOI: 10.3389/fneur.2021.805135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chauhan N, Soni S, Jain U. Recent advances in nanosensors development for biomarker alpha-synuclein protein detection. Process Biochemistry 2021;111:105-13. [DOI: 10.1016/j.procbio.2021.10.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Evidente VGH, Evidente DH, Ortega SC, Levine TD, Freeman R, Gibbons C. X-Linked Dystonia-Parkinsonism ("Lubag") May Present with Peripheral Synucleinopathy. Mov Disord 2021. [PMID: 34582053 DOI: 10.1002/mds.28801] [Reference Citation Analysis]
6 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Doppler K. Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease. J Parkinsons Dis 2021;11:937-47. [PMID: 33814464 DOI: 10.3233/JPD-202489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Miglis MG, Zitser J, Schneider L, During E, Jaradeh S, Freeman R, Gibbons CH. Cutaneous Alpha-Synuclein is Correlated with Autonomic Impairment in Isolated REM Sleep Behavior Disorder. Sleep 2021:zsab172. [PMID: 34244806 DOI: 10.1093/sleep/zsab172] [Reference Citation Analysis]
9 Dean DN, Lee JC. Linking Parkinson's Disease and Melanoma: Interplay Between α-Synuclein and Pmel17 Amyloid Formation. Mov Disord 2021;36:1489-98. [PMID: 34021920 DOI: 10.1002/mds.28655] [Reference Citation Analysis]
10 Andréasson M, Svenningsson P. Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluids. Curr Opin Neurol 2021;34:572-7. [PMID: 33967199 DOI: 10.1097/WCO.0000000000000948] [Reference Citation Analysis]